A Texas doctor who started using and promoting this treatment to patients back in March 2020 was pilloried for it and censored on social media.
In patients in the community with #COVID19 aged ≥65 years or ≥50 years with comorbidities, inhaled #budesonide reduced time to first self-reported recovery—an estimated 2.94 days sooner than usual care group, PRINCIPLE trial indicates.
Read: https://t.co/ir4Bn4dlW3 pic.twitter.com/3E66TI8SPI
— The Lancet (@TheLancet) August 11, 2021
From The Pharmaceutical Journal:
Trial demonstrates efficacy of inhaled budesonide to treat COVID-19 in the community
Findings from the PRINCIPLE trial suggest that inhaled budesonide can improve recovery time and could reduce hospital admissions or death from COVID-19 if administered early.
